154 related articles for article (PubMed ID: 31004444)
41. Synchronous bilateral non-Hodgkin's diffuse large B-cell lymphoma of the breast and left breast invasive ductal carcinoma: a case report and review of literature.
Liu W; Zhu H; Zhou X
Int J Clin Exp Pathol; 2014; 7(10):7042-8. PubMed ID: 25400793
[TBL] [Abstract][Full Text] [Related]
42. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Zammit C; Yelland A; Deutsch G
Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550708
[No Abstract] [Full Text] [Related]
43. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Tjalma WA
Lancet; 2003 Oct; 362(9390):1156-7. PubMed ID: 14550711
[No Abstract] [Full Text] [Related]
44. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
45. Mantle cell lymphoma with diminished expression of B-cell antigens: an unusual presentation.
Virk H; Sreedharanunni S; Sachdeva MUS; Das A
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32675125
[No Abstract] [Full Text] [Related]
46. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
Dhot PS; Sharma MC; Kumar L; Saxena R
J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
[No Abstract] [Full Text] [Related]
47. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Cunnick GH; Mokbel K
Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550707
[No Abstract] [Full Text] [Related]
48. Synchronous bilateral primary breast lymphoma: MRI and pathologic findings.
Woo OH; Yong HS; Shin BK; Park CM; Kang EY
Breast J; 2007; 13(4):429-30. PubMed ID: 17593055
[No Abstract] [Full Text] [Related]
49. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract][Full Text] [Related]
50. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
[TBL] [Abstract][Full Text] [Related]
51. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
[TBL] [Abstract][Full Text] [Related]
52. Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation.
Deutsch M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):687-91. PubMed ID: 12062613
[TBL] [Abstract][Full Text] [Related]
53. Adjuvant treatment of breast cancer with exemestane.
Kunkler IH
N Engl J Med; 2004 Jul; 351(1):100-2; author reply 100-2. PubMed ID: 15229316
[No Abstract] [Full Text] [Related]
54. Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?
Espinet B; Solé F; Pedro C; Garcia M; Bellosillo B; Salido M; Florensa L; Camacho FI; Baró T; Lloreta J; Serrano S
Hum Pathol; 2005 Nov; 36(11):1232-7. PubMed ID: 16260278
[TBL] [Abstract][Full Text] [Related]
55. A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.
Urquhart A; Borges V; Rabinovitch R; Singh M; Robinson W; Seligman P; Arya J; Finlayson C; Elias A
Oncology (Williston Park); 2005 Mar; 19(3):278, 283-4, 287 passim. PubMed ID: 15828548
[No Abstract] [Full Text] [Related]
56. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
Baroni G; Pedotti A; Orecchia R
Lancet; 2003 Oct; 362(9390):1155; author reply 1155-6. PubMed ID: 14550709
[No Abstract] [Full Text] [Related]
57. Transformation of indolent mantle cell lymphoma to pleomorphic mantle cell lymphoma: case report and review of clinical and morphologic variants.
Kiel MJ; Smith LB
Arch Pathol Lab Med; 2012 Aug; 136(8):871-5. PubMed ID: 22849733
[TBL] [Abstract][Full Text] [Related]
58. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
59. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
Ogawa Y; Nishioka A; Inomata T; Hamada N; Terashima M; Yoshida S; Tanaka Y; Ogoshi S; Araki K; Kumon M
Radiat Med; 1994; 12(1):29-35. PubMed ID: 8016401
[TBL] [Abstract][Full Text] [Related]
60. [Evaluation of immediate breast reconstruction and radiotherapy: factors associated with complications].
Gross E; Hannoun-Levi JM; Rouanet P; Houvenaeghel G; Teissier E; Ellis S; Resbeut M; Tallet A; Vaini Cowen V; Azria D; Cowen D
Cancer Radiother; 2010 Dec; 14(8):704-10. PubMed ID: 20674442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
